Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
426 participants
OBSERVATIONAL
2008-10-31
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Development of a Virtual Reality Program to Improve Attention in Individuals With TBI
NCT03605017
Computerized Attention Training for Individuals With Acquired Brain Injury
NCT01641432
Testing Devices That Involve the Sense of Touch in Subjects With Traumatic Brain Injury
NCT01404494
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
NCT06413173
Using Non-invasive Brain Stimulation to Treat Word Finding Difficulty in Chronic Traumatic Brain Injury
NCT06848140
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Testing will be conducted at two sites:
1. Civilians with mTBI; and civilians with adult attention deficit hyperactivity disorder will be tested by trained staff of the Brain Trauma Foundation (BTF) at Weill Cornell Medical College (WCMC) in New York City. The ages of the enrolled individuals will range between 18-55 years in order to examine aging effects.
2. Enrolled service members will be tested at the United States Army Research Institute of Environmental Medicine (USARIEM) in Natick, Massachusetts. These service members will be healthy volunteers without a history of mTBI. Some of these subjects will undergo 26 hours of sleep deprivation during which they will be tested at specific time points.
Our objectives are:
1\. Prove that the eye-tracking concept can be brought from a successful laboratory device to a specific, reliable, selective, and valid diagnostic tool.
1.1. Test reliability by examining the test-retest reliability measures of EYE-TRAC;
1.2. Test selectivity by testing the ability to differentiating the effects of fatigue, aging, and mTBI on EYE-TRAC measures;
1.3. Test validity by determining the relationship between measures of attention and working memory based on the EYE-TRAC and validated measures of sustained attention and working memory;
1.4. Test specificity by measuring the spectrum of TBI injury using MRI-DTI and correlate with EYE-TRAC.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TBI Patients
Individuals who have suffered a mild traumatic brain injury and have persistent post-concussive symptoms (PCS)
No interventions assigned to this group
Normals
Individuals of comparable age and education who have not suffered a traumatic brain injury
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Education up to 12th grade
* Education up to 12th grade
* Persistent post concussive symptoms after an isolated incident of head injury with or without loss of consciousness between 3 months to 5 years prior to participation
Exclusion Criteria
* Alcohol or substance abuse problems, neurological disorders, major psychiatric disorders (including ADHD or PTSD)
* Gross visual or hearing problems
* Pregnancy
* Metal in the body or any contraindications for MRI
TBI Patients:
* Prior history of seizures
* Pregnant woman
* Alcohol or substance abuse problems, neurological disorders, major psychiatric disorders (including ADHD or PTSD)
* Gross visual or hearing problems
* Any metal in the body or contraindications for MRI
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Department of Defense
FED
Brain Trauma Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jamshid Ghajar, M.D., Ph.D.
President
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jamshid Ghajar, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Brain Trauma Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Citigroup Imaging Center, Weill Medical College of Cornell University
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB Protocol #0211005884
Identifier Type: -
Identifier Source: secondary_id
PT075553
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.